Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of 90-Y-Humanized-BrE-3 Followed by Autologous Hematopoietic Progenitor Cell Support in Patients With Metastatic Breast Cancer

NCT00007891 is registered in ClinicalTrials.gov with Cancer Research Institute of Contra Costa as lead sponsor.

NCT NCT00007891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00007891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of 90-Y-Humanized-BrE-3 Followed by Autologous Hematopoietic Progenitor Cell Support in Patients With Metastatic Breast Cancer
Lead sponsor
Cancer Research Institute of Contra Costa
Phase
Phase 1
Overall status
Completed
Start date
June 30, 1997
Completion date
October 31, 2004
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer